X0202 4/A 2003-12-19 2004-06-03 0 0001145404 CRITICAL THERAPEUTICS INC CRTX 0001291763 Phillips Trevor C/O CRITICAL THERAPEUTICS, INC. 60 WESTVIEW STREET LEXINGTON MA 02421 0 1 0 0 COO, VP of Operations and Sec. Common Stock 2004-01-09 4 M 0 21944.0000 0.3750 A 21944.0000 D Options to Purchase 1.0500 2003-12-19 4 A 0 176926.0000 A 2013-12-19 Common Stock 176926.0000 176926.0000 D Options to Purchase 0.3750 2004-01-09 4 M 0 21944.0000 D 2012-10-09 Common Stock 21944.0000 4722.0000 D Series B Convertible Preferred Stock 2004-03-05 4 P 0 6000.0000 1.4000 A Common Stock 1600.0000 12000.0000 D These securities transactions were unintentionally omitted on the Form 4 filed by the reporting person. One-quarter of the options to purchase 176,926 shares of Common Stock of the Issuer vested on December 19, 2003. An additional one-quarter of such options vest under a schedule providing for one-quarter to become exercisable on December 19, 2004 and three-quarters to become exercisable in 36 equal monthly installments beginning one month thereafter. The remainder of such options vest in four equal annual installments on each of December 31, 2004, 2005, 2006 and 2007. Not applicable. Of the options to purchase 26,666 shares of Common Stock of the Issuer originally granted, three-quarters of such options vested on October 15, 2002. The remainder of such options vest upon completion of a set of goals agreed to by Dr. Phillips and the board of directors. The Series B Convertible Preferred Stock converted into Common Stock of the Issuer on a one-for-3.75 basis upon the closing of the Issuer's initial public offering. These shares were immediately convertible into Common Stock of the Issuer. They had no expiration date. The share numbers and prices set forth in this report reflect the one-for-3.75 reverse stock split of the Common Stock of the Issuer effected on May 20, 2004. /s/ Trevor Phillips 2004-06-28